Breathing After COVID-19

June 26, 2021 updated by: Hilal Hotaman, Trakya University

Thoracal Motion After COVID-19 Disease

This research; It will be done to perform thoracic movement analysis of young adult individuals who have survived COVID-19 and to compare them with those without a history of COVID-19.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This research; It will be done to perform thoracic movement analysis of young adult individuals who have survived COVID-19 and to compare them with those without a history of COVID-19.

Individuals' sternal movements using motion analysis sensors; will be recorded in sitting position, standing, and walking. Sternal movement of the person; It will be recorded during relaxed breathing and deep breathing. They will also be asked to walk on the treadmill in such a way as to collect at least 500 steps.

Study Type

Observational

Enrollment (Anticipated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Healthy individuals who have a COVID-19 illness history or have no COVID-19 history will be the participants of the study.

Description

Inclusion Criteria:

  • to be voluntary.
  • have COVID-19 illness history.
  • No COVID-19 illness history.
  • treated by a standard medical treatment (vitamins, blood thinners, anti-viral drugs)

Exclusion Criteria:

  • have another chronic disease such as systemic, orthopedic or neurologic.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Individuals who have had COVID-19.
Individuals who have had COVID-19 and who treated by a standart medical treatment at home.
Other: No intervention.
No intervention.
Individuals who have not a COVID-19 illness history.
Other: No intervention.
No intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thoracal motion while normal breathing at sitting.
Time Frame: At first day.
Sensor - based thoracal motion assesment while normal breathing at sitting will be utilized.
At first day.
Thoracal motion while normal breathing at standing.
Time Frame: At first day.
Sensor - based thoracal motion assesment while normal breathing at standing will be utilized.
At first day.
Thoracal motion while deep breathing at sitting.
Time Frame: At first day.
Sensor - based thoracal motion assesment while normal breathing at sitting will be utilized.
At first day.
Thoracal motion while deep breathing at standing.
Time Frame: At first day.
Sensor - based thoracal motion assesment while deep breathing at standing will be utilized.
At first day.
Thoracal motion at walk.
Time Frame: At first day.
Sensor - based thoracal motion assesment at walk will be utilized.
At first day.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Trakya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 25, 2021

Primary Completion (Anticipated)

June 30, 2021

Study Completion (Anticipated)

July 30, 2021

Study Registration Dates

First Submitted

June 16, 2021

First Submitted That Met QC Criteria

June 26, 2021

First Posted (Actual)

June 29, 2021

Study Record Updates

Last Update Posted (Actual)

June 29, 2021

Last Update Submitted That Met QC Criteria

June 26, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021/64

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on No intervention.

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe